- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Medical Bulletin 23/June/2026 - Video
Overview
Here are the top medical news for today:
New Study Links GLP-1 Medications to Higher Testosterone and Better Sperm Count
Men taking GLP-1 medications for weight loss or diabetes may gain an unexpected benefit beyond improved metabolic health—better fertility, according to new research presented at the Endocrine Society's ENDO 2026 meeting.
Researchers found that after 24 weeks of GLP-1 treatment, men aged 18 to 65 with obesity experienced improvements in testosterone levels, sperm count, and sperm quality, including healthier size and shape. The findings suggest these widely used medications may positively influence male reproductive health, although experts stress that larger studies are still needed before GLP-1 drugs can be recommended specifically to treat infertility.
Male infertility contributes to more than half of infertility cases among couples who struggle to conceive. Researchers believe the benefits seen with GLP-1 medications may be largely driven by weight loss, which can improve hormone balance, particularly testosterone production. The drugs may also reduce inflammation and metabolic stress, both of which are known to impair sperm production.
Unlike testosterone replacement therapy, which can suppress sperm production despite increasing testosterone levels, GLP-1 medications could potentially improve both hormone levels and fertility simultaneously. However, researchers caution that the current study only included men with a high body mass index, so the findings cannot yet be applied to men of normal weight.
Experts also note that obesity is not the only cause of male infertility. Hormonal disorders can sometimes contribute to weight gain rather than result from it, making a proper fertility evaluation important before starting treatment. They also caution that rapid weight loss—whether through bariatric surgery or, in some cases, GLP-1 medications—may temporarily affect fertility by signaling to the body that conditions are not ideal for reproduction.
Alongside medical care, maintaining a healthy weight, exercising regularly, eating fewer ultra-processed foods, getting enough sleep, avoiding smoking and excessive alcohol, limiting exposure to environmental toxins, and reducing frequent exposure to high heat, such as hot tubs, may all help support male fertility and overall reproductive health.
REFERENCE: Clinical trials suggest GLP-1s may improve fertility in men with obesity; ENDO 2026- Endocrine Society’s annual meeting in Chicago, Ill; https://www.endocrine.org/news-and-advocacy/news-room/2026/natesh-press-release-endo-2026
New Study Shows Diet Can Rewire Gut Microbiome Using Synthetic Microbial Communities
Scientists are increasingly turning to synthetic microbial communities (SynComs) to better understand how the foods we eat influence gut bacteria and, ultimately, human health, according to a new review published in npj Biofilms and Microbiomes.
The human gut contains trillions of microorganisms that play essential roles in digestion, vitamin production, immune function, and metabolism. Diet is one of the strongest factors shaping this microbial ecosystem, but studying its effects is challenging because hundreds of different microbes interact simultaneously. SynComs offer a solution by creating simplified, well-defined microbial communities that allow researchers to examine how specific dietary components affect gut microbes under controlled conditions.
Unlike the natural gut microbiome, SynComs contain carefully selected microbial species that represent key functions such as carbohydrate breakdown, short-chain fatty acid production, bile acid metabolism, and interactions between microbes.
Researchers use SynComs in laboratory systems ranging from simple batch cultures to advanced gut-on-a-chip platforms that closely mimic the human intestine. They are also combined with germ-free animal models to study how gut microbes affect immune development, metabolism, intestinal barrier function, and disease risk.
Studies using SynComs have shown that high-fiber diets encourage beneficial bacteria that produce health-promoting short-chain fatty acids, while high-fat diets tend to favor bile-tolerant microbes. Protein-rich diets, meanwhile, can increase bacteria involved in amino acid fermentation.
The review highlights SynComs as valuable tools for studying conditions linked to the gut microbiome, including obesity, type 2 diabetes, inflammatory bowel disease, colorectal cancer, allergies, asthma, and neurodevelopmental disorders. They are also being used to evaluate
Researchers believe these innovations could eventually support personalized nutrition strategies and microbiome-based therapies tailored to an individual's unique gut ecosystem.
REFERENCE: Senoo, D. K. J., Acton, L., & Hall, L. J. (2026). From diet to function: Using synthetic microbial communities to map gut microbial interactions. npj Biofilms and Microbiomes. DOI: 10.1038/s41522-026-01012-9, https://www.nature.com/articles/s41522-026-01012-9
Scientists Discover Neurons Must Break DNA to Build the Developing Brain
New brain cells may briefly damage their own DNA as they squeeze through the crowded developing brain, according to a new study published in Nature. Researchers found that these DNA breaks are a normal part of brain development and are usually repaired within a day, allowing neurons to continue developing normally.
During early brain development, newly formed neurons must migrate through tightly packed brain tissue to reach their final positions in the cerebral cortex, where they form neural circuits. To investigate what happens during this journey, researchers from Kyoto University and collaborating institutions recreated these confined conditions by guiding neurons through tiny microchannels that mimic the narrow spaces in the developing brain.
The team found that as neurons squeezed through these tight spaces, they frequently developed DNA double-strand breaks—one of the most severe forms of DNA damage, in which both strands of the DNA helix are cut. However, once the neurons completed their migration, most of the damage was repaired within 24 hours, and the cells continued to function normally.
Further experiments showed that the damage was caused by Topoisomerase IIβ, an enzyme that normally relieves twisting and mechanical stress in DNA by temporarily cutting and reconnecting DNA strands. Under the physical strain of migration, the enzyme sometimes became trapped before completing the repair, leaving DNA temporarily broken. The cells then repaired these breaks using a process called non-homologous end joining.
Unlike cancer cells, where similar mechanical stress can cause widespread and harmful DNA damage, neurons largely confined these breaks to regions of the genome that are not essential for critical gene activity. This selective pattern likely helps preserve normal brain development despite the temporary DNA damage.
To understand what happens when repair fails, researchers engineered mice lacking Ligase 4, a key DNA repair enzyme, in newly formed cerebellar neurons. Although the mice developed normally, they gradually developed mild balance problems in adulthood, resembling certain human neurological disorders linked to defective DNA repair.
The researchers believe these findings reshape our understanding of brain development, suggesting that temporary DNA damage and repair may be a natural part of neuronal maturation.
REFERENCE: Zhejing Zhang, Andres Canela, Junko Kurisu, Peilin Zou, Takumi Kawaue, Naotaka Nakazawa, Noriko Takeda, Mai Saeki, Masaki Utsunomiya, Merve Bilgic, Fumiyoshi Ishidate, Gianluca Grenci, Takahiro Furuta, Yusuke Kishi, Hiroyuki Sasanuma, Mineko Kengaku. Confined migration induces non-lethal DNA damage in developing neurons. Nature, 2026; DOI: 10.1038/s41586-026-10648-8


